These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 26609882

  • 1. Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).
    Yang Y, An S, Liu Y, Guo XX, Gao L, Wei JF, Xu TR.
    Expert Opin Ther Pat; 2016; 26(1):89-106. PubMed ID: 26609882
    [Abstract] [Full Text] [Related]

  • 2. 5-HT2 ligands in the treatment of anxiety and depression.
    Quesseveur G, Nguyen HT, Gardier AM, Guiard BP.
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1701-25. PubMed ID: 22917059
    [Abstract] [Full Text] [Related]

  • 3. "Selectivity": an attractive but often misleading notion.
    Prescrire Int; 2014 May; 23(149):120. PubMed ID: 24926509
    [No Abstract] [Full Text] [Related]

  • 4. Serotonin in the pathophysiology and treatment of CNS disorders.
    Di Giovanni G.
    Exp Brain Res; 2013 Oct; 230(4):371-3. PubMed ID: 24057054
    [No Abstract] [Full Text] [Related]

  • 5. 5-HT2C receptor modulators: a patent survey.
    Lee J, Jung ME, Lee J.
    Expert Opin Ther Pat; 2010 Nov; 20(11):1429-55. PubMed ID: 20849206
    [Abstract] [Full Text] [Related]

  • 6. The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research.
    Devroye C, Cathala A, Piazza PV, Spampinato U.
    Pharmacol Ther; 2018 Jan; 181():143-155. PubMed ID: 28757154
    [Abstract] [Full Text] [Related]

  • 7. From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists.
    Higgins GA, Sellers EM, Fletcher PJ.
    Trends Pharmacol Sci; 2013 Oct; 34(10):560-70. PubMed ID: 24041919
    [Abstract] [Full Text] [Related]

  • 8. Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs.
    Meltzer HY, Roth BL.
    J Clin Invest; 2013 Dec; 123(12):4986-91. PubMed ID: 24292660
    [Abstract] [Full Text] [Related]

  • 9. Atypical antipsychotics and inverse agonism at 5-HT2 receptors.
    Sullivan LC, Clarke WP, Berg KA.
    Curr Pharm Des; 2015 Dec; 21(26):3732-8. PubMed ID: 26044975
    [Abstract] [Full Text] [Related]

  • 10. New therapeutic opportunities for 5-HT2 receptor ligands.
    Maroteaux L, Ayme-Dietrich E, Aubertin-Kirch G, Banas S, Quentin E, Lawson R, Monassier L.
    Pharmacol Ther; 2017 Feb; 170():14-36. PubMed ID: 27771435
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic Potential of 5-HT2C Receptor Agonists for Addictive Disorders.
    Higgins GA, Fletcher PJ.
    ACS Chem Neurosci; 2015 Jul 15; 6(7):1071-88. PubMed ID: 25870913
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic potential of 5-HT2C receptor ligands.
    Jensen NH, Cremers TI, Sotty F.
    ScientificWorldJournal; 2010 Sep 14; 10():1870-85. PubMed ID: 20852829
    [Abstract] [Full Text] [Related]

  • 13. The serotonin-2 receptor modulator, (-)-trans-PAT, decreases voluntary ethanol consumption in rats.
    Kasper J, Tikamdas R, Kim MS, Macfadyen K, Aramini R, Ladd J, Bisceglia S, Booth R, Peris J.
    Eur J Pharmacol; 2013 Oct 15; 718(1-3):98-104. PubMed ID: 24041931
    [Abstract] [Full Text] [Related]

  • 14. Novel oxytocin receptor agonists and antagonists: a patent review (2002 - 2013).
    Yang Y, Li H, Ward R, Gao L, Wei JF, Xu TR.
    Expert Opin Ther Pat; 2014 Jan 15; 24(1):29-46. PubMed ID: 24094047
    [Abstract] [Full Text] [Related]

  • 15. Function and distribution of 5-HT2 receptors in the honeybee (Apis mellifera).
    Thamm M, Rolke D, Jordan N, Balfanz S, Schiffer C, Baumann A, Blenau W.
    PLoS One; 2013 Jan 15; 8(12):e82407. PubMed ID: 24324783
    [Abstract] [Full Text] [Related]

  • 16. Serotonin-enhanced hyperactivation of hamster sperm.
    Fujinoki M.
    Reproduction; 2011 Aug 15; 142(2):255-66. PubMed ID: 21555358
    [Abstract] [Full Text] [Related]

  • 17. Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development.
    Wold EA, Wild CT, Cunningham KA, Zhou J.
    Curr Top Med Chem; 2019 Aug 15; 19(16):1381-1398. PubMed ID: 31288724
    [Abstract] [Full Text] [Related]

  • 18. Elevated cyclic stretch and serotonin result in altered aortic valve remodeling via a mechanosensitive 5-HT(2A) receptor-dependent pathway.
    Balachandran K, Hussain S, Yap CH, Padala M, Chester AH, Yoganathan AP.
    Cardiovasc Pathol; 2012 Aug 15; 21(3):206-13. PubMed ID: 21865058
    [Abstract] [Full Text] [Related]

  • 19. Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2.
    Podlewska S, Bugno R, Lacivita E, Leopoldo M, Bojarski AJ, Handzlik J.
    Int J Mol Sci; 2021 Jan 21; 22(3):. PubMed ID: 33494248
    [Abstract] [Full Text] [Related]

  • 20. Serotonin modulates response properties of neurons in the dorsal cochlear nucleus of the mouse.
    Felix RA, Elde CJ, Nevue AA, Portfors CV.
    Hear Res; 2017 Feb 21; 344():13-23. PubMed ID: 27838373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.